Jaime Bartushak - 12 Dec 2024 Form 4 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTOR	Stock Option (Right to Buy)	Award	$0	+400,000		$0.000000	400,000	12 Dec 2024	Common Stock	400,000	$1.07	Direct	F1
holding	CTOR	Stock Option (Right to Buy)						1,400,000	12 Dec 2024	Common Stock	1,400,000	$2.15	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date.
F2	These options vest over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services Continuous Service to the Company as of each such vesting date.